Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299206 · ClinicalTrials.gov registry record · NA
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02299206 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants.
The verdict
NCT02299206, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a single-center, 1:1 randomized, double-blind, parallel-group, non-inferiority controlled trial to demonstrate non-inferiority of CeraVe Baby Diaper Rash Cream compared to Desitin Maximum Strength Original Paste when administered to children with diaper dermatitis who are between 3 months to 18 months of age. Parents/caregivers of subjects in both groups will administer the product with each diaper change throughout the course of the study period. Product can be applied liberally as needed. Diapers and skin cleansing interventions will stay constant throughout the treatment period. Subjects will be assessed by the study doctor, parent/caregiver will be asked about any adverse effects. Parent/caregivers will also be asked to complete a daily diary that asks about changes in their baby's diaper dermatitis, a Visual Analogue Scale severity assessment of their baby's diaper dermatitis, and observations related to product use and the baby's comfort level. Parents/caregivers will also be given a questionnaire rating the use of the study products.
Interventions
- DRUG CeraVe Baby Diaper Rash Cream
- DRUG Desitin Maximum Strength Original Paste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02299206
The ClinicalTrials.gov registry entry for NCT02299206 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CeraVe Baby Diaper Rash Cream is the first listed.
NCT02299206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02299206 about?
NCT02299206 is a clinical study titled "CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants". This is a single-center, 1:1 randomized, double-blind, parallel-group, non-inferiority controlled trial to demonstrate non-inferiority of CeraVe Baby Diaper Rash Cream compared to Desitin Maximum Strength Original Paste when administered to children with diaper dermatitis who are between 3 months to...
What is the current status of trial NCT02299206?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-12. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02299206?
The interventions under investigation include: CeraVe Baby Diaper Rash Cream (DRUG), Desitin Maximum Strength Original Paste (DRUG).
Who is sponsoring clinical trial NCT02299206?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.